Chengdu Kanghong Pharm
ISIN CNE1000020C4
|WKN A2DSJX
Overview
Description
Chengdu Kanghong Pharmaceutical Group Co., Ltd. engages in the research, development, production and sale of Chinese patent medicines, chemical medicines and biological products. Its products include Conbercept Ophthalmic Injection, Shugan Jieyu Jiaonang, Ganke Shuangqing Jiaonang, Yiqing Jiaonang, Venlafaxine Hydrochloride Capsules, Xuan Maigangu, Aripiprazole, Keluoxin, Danshu Jiaonang, Mosapride Citrate, and Dexzopiclone. The company was founded on October 3, 1996 and is headquartered in Chengdu, China.
Healthcare Biopharmaceuticals Other Biopharmaceuticals China
Financials
Key metrics
| Market capitalisation, EUR | 2,487.74 m |
| EPS, EUR | 0.16 |
| P/B ratio | 2.39 |
| P/E ratio | 17.16 |
| Dividend yield | 1.79% |
Income statement (2023)
| Revenue, EUR | 509.85 m |
| Net income, EUR | 136.54 m |
| Profit margin | 26.78% |
What ETF is Chengdu Kanghong Pharm in?
There are 3 ETFs which contain Chengdu Kanghong Pharm. All of these ETFs are listed in the table below. The ETF with the largest weighting of Chengdu Kanghong Pharm is the VanEck New China ESG UCITS ETF A.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| VanEck New China ESG UCITS ETF A | 1.38% | Equity China Growth | 100 | 0.60% | 4 | -18.89% | A3CR8S | IE0000H445G8 |
| Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing | 0.00% | Equity Emerging Markets Social/Environmental | 3,552 | 0.24% | 18 | +10.95% | A3DJRD | IE0001VXZTV7 |
| Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Accumulating | 0.00% | Equity Emerging Markets Social/Environmental | 3,552 | 0.24% | 22 | +10.88% | A3DJRC | IE000KPJJWM6 |
Order fees
Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
Order volume:
| Broker | Rating | Order fee | Stock savings plans | |
|---|---|---|---|---|
 | 0.99€ | 1000 | View offer* | |
 | 0.00€ | 2500 | View offer* | |
 | 0.00€ | 500 | View offer* | |
 | 0.00€ | 300 | View offer* | |
 | 5.90€ | - | View offer* |
Source: justETF Research; As of 8/2024; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.